当前位置:首页 > 文献互助 > 互助详情

Results of Phase I Tolerability LX214 (0.2%) Voclosporin Topical Solution in Healthy Volunteers and Subjects With Dry Eye Disease复制

用户qgRSP4os3S6M 24天前 36 10 已关闭

DOI:复制

文献链接:复制

其他信息:

MA Lemp, R Beckman, S Weiss
… Ophthalmology & Visual …, 2010
iovs.arvojournals.org
… Systemic voclosporin exposure was assessed with pharmacokinetic measurement in … with Dry Eye Disease was seen at 2 weeks. Systemic exposure of voclosporin was minimal. …

互助时间线

2025-09-10 16:52:00 [发起求助]